RxDoctor Payments Data

Kit Tam

Hematology & Oncology · Sacramento, CANPI 1972732014

Payments from drug & device makers

$216,046in general payments, 2019–2025

Across 6 payments — averaging $36,008 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • E.r. Squibb & Sons, L.L.C.$216K

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
E.r. Squibb & Sons, L.L.C.6$216,046

How this compares

$216,046 in reported general payments places this provider in the 75th percentile of 1,363 hematology & oncology providers in California.

See all hematology & oncology providers in California

Medicare billing

Part B allowed, 2024
$102,144
Medicare patients
165
Services billed
1,524

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Sunitinib Malate14$102,337
BraftoviEncorafenib12$96,496
EliquisApixaban12$12,946
Ondansetron Hcl51$717
LoperamideLoperamide Hcl25$491
Prochlorperazine Maleate33$460
Lidocaine Hcl ViscousLidocaine Hcl18$340
Oxycodone Hcl24$310
Dexamethasone14$133

Paid to pharmacies, not to this prescriber.

Other hematology & oncology in Sacramento

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →